Medical Data Vision completes share repurchase program

Medical Data Vision announced the completion of its share repurchase program, which was initially authorized by the board of directors on September 27, 2024. The company repurchased 340,000 shares during the program at a total cost of JPY 152,527,800. Although the board had approved the repurchase of up to 2,000,000 shares, representing a total acquisition cost of up to JPY 1,000,000,000, the company ultimately did not reach these limits, citing financial conditions and market considerations. The actual repurchase period spanned from September 30, 2024, to March 31, 2025, and was executed through market purchases on the Tokyo Stock Exchange. The total number of shares repurchased represents approximately 5.24% of outstanding shares (excluding treasury stock).